Medicine and Dentistry
Ovarian Cancer
100%
Malignant Neoplasm
84%
Neoplasm
71%
Krukenberg Tumor
47%
Endometrial Cancer
47%
Gynecological Oncology
46%
Disease
43%
Cervical Cancer
39%
Overall Survival
27%
Oncology
26%
Wart Virus
26%
Female Genital Tract Cancer
26%
Recurrent Disease
25%
Cancer Cell
22%
Cancer
21%
Cervical Cancer Screening
19%
Quality of Life
16%
Carboplatin
16%
Breast Cancer
16%
Cross Sectional Study
16%
Progression Free Survival
15%
Endometrium Carcinoma
15%
Natural Killer Cell
14%
Cancer Therapy
14%
Paclitaxel
14%
COVID-19
14%
Hysterectomy
13%
Pelvis
13%
Cytotechnology
13%
Biological Marker
12%
Metastatic Carcinoma
12%
Radiation Therapy
12%
Surgery
12%
Retroperitoneal Lymph Node Dissection
11%
Symptom
11%
Nodular Melanoma
10%
Randomized Controlled Trial
10%
Infection
10%
Laparotomy
10%
Immunohistochemistry
10%
Papanicolaou Stain
10%
Health Care Cost
9%
Adjuvant Therapy
9%
In Vitro
9%
Clear Cell
9%
Cervix
9%
Squamous Cell Carcinoma
8%
Ovarian Tumor
8%
Immunotherapy
8%
Carcinosarcoma
8%
Carcinoma
8%
Patient Referral
8%
Colposcopy
7%
Odds Ratio
7%
Oncologist
7%
Hazard Ratio
7%
Arm
7%
Laparoscopy
7%
Adenocarcinoma
7%
Lymph Node
7%
Prevalence
7%
CA-125
7%
Diagnosis
6%
Primary Tumor
6%
Cancer Risk
6%
Cervical Intraepithelial Neoplasia
6%
Adjuvant Chemotherapy
6%
Gene Expression
6%
Sun Exposure
6%
Surgeon
6%
Kaplan Meier Method
6%
Gynecology
6%
Drug Resistance
6%
Wound
6%
Cytoreductive Surgery
6%
DNA Mismatch Repair
6%
Targeted Therapy
6%
Papillomavirus Infection
5%
Primary Health Care
5%
Vulva
5%
Cancer Diagnosis
5%
Clear Cell Carcinoma
5%
Minimal Residual Disease
5%
Cisplatin
5%
Xenograft
5%
Pandemic
5%
Uterine Cervix Cytology
5%
Phase II Trials
5%
Prospective Cohort Study
5%
Proteasome
5%
Human Immunodeficiency Virus
5%
Uterine Cervix Carcinoma
5%
Health Care
5%
Severe Acute Respiratory Syndrome Coronavirus 2
5%
Single Nucleotide Polymorphism
5%
Nanotube
5%
Gestational Trophoblastic Disease
5%
Cesarean Section
5%
Vulvar Cancer
5%
Logistic Regression Analysis
5%
Keyphrases
Ovarian Cancer
78%
Tumor
51%
Endometrial Cancer
37%
Chemotherapy
33%
Whole Genome
31%
Cervical Cancer
29%
Gynecologic Oncology Group
29%
Natural Killer Cells
27%
Pan-cancer Analysis
27%
Epithelial Ovarian Cancer
25%
Overall Survival
24%
Cervical Cancer Screening
24%
In Cancer
23%
Paclitaxel
21%
Gynecologic Oncology
21%
NRG Oncology
20%
Ovarian Cancer Cells
20%
High-risk Human Papillomavirus (HR-HPV)
19%
Human Cancer
18%
Gynecological Cancer
18%
Confidence Interval
16%
Group Studies
16%
Carboplatin
16%
Advanced Ovarian Cancer
15%
United States
14%
Phase II Trial
14%
Progression-free Survival
13%
Gynecologic Malignancies
13%
Cancer Patients
12%
Ovarian Cancer Patients
12%
Endometrioid
12%
Gynecologic Cancer Survivors
12%
Laparotomy
11%
Colorectal Cancer
11%
Molecular Characterization
11%
Cancer Treatment
11%
Endometrial Carcinoma
11%
High Risk
11%
Cervical Carcinoma
10%
COVID-19
10%
High-grade Serous Ovarian Cancer (HGSOC)
10%
Young Women
10%
Ovarian Carcinoma
10%
COVID-19 Pandemic
10%
Quality of Life
9%
Adjuvant Therapy
9%
Sleeping Beauty Transposon
9%
Cancer Cells
8%
Tumor Subtype
8%
Immunohistochemistry
8%
Cancer Types
8%
Tunneling Nanotubes
8%
Oncology Patients
8%
Overexpression
8%
Healthcare Professionals
8%
Deubiquitinating Enzyme
7%
Radiation Therapy
7%
Colposcopy
7%
Minnesota
7%
Odds Ratio
7%
Human Papillomavirus Testing
7%
Recurrent Ovarian Cancer
7%
Cancer Care
7%
Rwanda
7%
Hysterectomy
7%
Cancer Genome
7%
Risk Factors
7%
Randomized Controlled Trial
7%
Platinum-based Chemotherapy
7%
Carbohydrate Antigen 125 (CA125)
7%
Vulvar Squamous Cell Carcinoma
7%
Breast Cancer
7%
Survivors
7%
Uterine Serous Carcinoma
7%
Pap Test
7%
Uterus
7%
Advanced Stage
6%
Adjuvant Chemotherapy
6%
Ubiquitin-proteasome System
6%
Tumor Microenvironment
6%
Invasive Cervical Cancer
6%
Targeted Therapy
6%
Transposon
6%
T Cells
6%
Gene Signature
6%
Sleeping Beauty
6%
Cervical Intraepithelial Neoplasia
6%
Vulvar Cancer
6%
Single-cell RNA Sequencing (scRNA-seq)
6%
Gene Expression
6%
Melanoma Survivors
6%
Cancer Genes
6%
Metastasis
6%
Chemoresistant
6%
Solid Tumors
6%
Histology
6%
Cisplatin
6%
Human Pluripotent Stem Cells (hPSCs)
6%
UNC-45
6%
Histological Subtypes
6%